Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,338.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 40.00 (3.049%)
Market Cap: £613.15m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Year end and COVID-19 Update

21 May 2020 07:00

RNS Number : 5340N
Cohort PLC
21 May 2020
Β 

Β 

Β 

21 May 2020

Β 

COHORT PLC

("Cohort" or "the Group")

Β 

Year end and COVID-19 Update

Β 

Cohort, the independent technology group, today issues a trading update for its financial year ended 30 April 2020, and an update on its response to COVID-19.

Β 

Summary:

Β 

Β· With the benefit of a lower tax charge we anticipate FY20 earnings per share to be in line with market expectations

Β· FY20 Revenue expected to be c.Β£133m (2019: Β£121.2m)

Β· FY20 Adjusted* operating profit expected to be c.Β£18m (2019: Β£16.2m)

Β· FY20 Adjusted earnings per share expected to be c.35.0p (2019: 33.6p)

Β· Net debt at 30 April 2020 of c.Β£5m (30 April 2019: net debt Β£6.4m)

Β· A closing order book of c.Β£186m (30 April 2019:Β Β£190.9m)

Β· FY21's trading performance difficult to predict given COVID-19 impact but currently expected to be in line with FY20

Β 

*subject to audit; adjusted figures exclude the effects of marking forward exchange contracts to market value, other exchange gains and losses,

amortisation of other intangible assets and exceptional items.

Β 

COVID-19 response

Β 

In responding to the disruption caused by COVID-19, the wellbeing of all our employees remains paramount. The transition to having most employees work from home, and the adoption of social distancing measures for those unable to do so, was achieved quickly and efficiently. Fewer than 30% of the Group's employees are now working on site and many of these are working from home for part or most of the time. Nevertheless, our manufacturing sites have remained operational with enhanced health and safety measures in place.

Β 

A small minority of Group employees are on furlough leave, most of whom either are vulnerable individuals or have vulnerable dependents. Cost containment and cash preservation measures have been implemented across the Group including Board and senior management pay freezes for the coming financial year.

Β 

FY20 year end update

Β 

Cohort's performance was tracking broadly in line with expectations prior to the imposition of COVID-19 restrictions in the last two months of our financial year, typically our busiest period. We were assisted by the UK MOD's quick action to support its suppliers, including faster payments and simplification of some procedures.

Β 

Nevertheless, the restrictions have affected our ability to carry out work on customer premises and customers' ability to witness acceptance tests and to place new orders. This had some impact on our FY20 revenue and trading profit, although these still showed positive growth compared to FY19. With the benefit of a lower tax charge we anticipate FY20 earnings per share to be in line with market expectations.

Β 

Despite delays to orders caused by COVID-19 restrictions in the final quarter, order intake for the year was c.Β£125m, a satisfactory outcome compared to the record order intake of Β£189.9m in FY19 which included a number of large, long term awards. The expected year end order book of c.Β£186m is similar to the prior year (2019: Β£190.9m).

Β 

As at 30 April 2020, net debt stood at c.Β£5m (31 October 2019: net debt Β£6.8m; 30 April 2019: net debt Β£6.4m); this was better than both our forecast and the position at the last year-end and represents a net debt / EBITDA ratio of less than 0.3 (2019: 0.4).

Β 

The net debt comprised of gross cash of Β£20m and gross debt of Β£25m, together with a Β£5m undrawn facility, gives the Group access to Β£25m of available facilities. In addition, the Group has agreed with its banks to convert an existing Β£10m accordion into a committed facility. This will be used for the proposed acquisition of ELAC, the Germany-based market leader in naval surface ship and submarine sonar systems, that was announced in December 2019.

Β 

We remain in positive discussions with the German Federal Authorities about approval of the transaction. Both Cohort and WΓ€rtsilΓ€ are working hard to complete the transaction in June 2020 as originally planned, but COVID-19 restrictions are likely to result in some delay. We will provide a further update when the conditions for completion have been met.

Β 

Given the Group's satisfactory performance last year and strong balance sheet, the Board expects to recommend the payment of a final dividend for the year ended 30 April 2020 in line with our progressive policy of recent years. The decision will be announced as usual at the time of the Group's final results and will be subject to shareholder approval at the AGM.

Β 

FY21 Outlook

Β 

Cohort remains well placed, having entered the new financial year with a substantial long-term order book. The 30 April 2020 order book of c.Β£186m underpins nearly Β£83m (2019: Β£80m) of current financial year revenue, representing c.60% of expected revenue for the year. The Group has a number of significant new domestic and export opportunities, and extensions to existing contracts, being addressed at Chess, EID and MASS and with good prospects at MCL and SEA.

The potential impact of COVID-19 makes it more difficult than usual to provide guidance. At this early stage the Board expects that restrictions on international travel due to COVID-19 may result in short term constraints on export activity (which represented over 30% of Cohort's revenues in the year just ended). As a result, FY21 trading performance is currently expected to be in line with that achieved in FY20. If appropriate the Board will provide further updates during the current financial year.

In the longer term, the Group expects to return to growth, as it recovers the orders and revenue delayed due to COVID-19.

Β 

Notice of FY20 results

Β 

It is the Group's current intention to issue its final results for the year ended 30 April 2020 in July 2020. Given the recent guidance from the FRC around the potential complexity of the audit process under COVID-19 restrictions, the Group will confirm the proposed date in a later announcement.

Β 

Β 

Andrew Thomis, Chief Executive of Cohort, said:

"Cohort had a satisfactory year despite the impact of COVID-19 on the business in the last two months of our financial year. We successfully transitioned to most employees working from home, with the adoption of social distancing measures for those unable to do so. We have a robust financial position, a strong order book underpinning 60% of expected current year revenues, and an encouraging pipeline of order opportunities across the business.

Β 

"Overall, as a result of the impact of COVID-19 we expect trading performance in the coming financial year to be in line with that achieved in 2019/20."

Β 

Β 

EndsΒ 

Β 

For further information, please contact:

Β 

Cohort plc

Β 

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

Β 

Β 

Β 

Β 

Investec Bank plc

Β 

020 7597 5970

Daniel Adams / Chris Baird

Β 

Β 

Β 

Β 

Β 

MHP Communications

Β 

020 3128 8100

Reg Hoare / Pete Lambie / Alice McLaren

Β 

cohort@mhpc.com

Β 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company of five innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers systems and technologies for detecting, tracking, classifying and disrupting naval, land and air threats. It was acquired by Cohort plc in December 2018. www.chess-dynamics.com & www.vision4ce.com

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.Β www.mass.co.uk

MCL - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007. www.sea.co.uk

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Reading, Berkshire and employs in total around 950 core staff there and at its other operating company sites across the UK and in Portugal.

Β 

All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which Cohort operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and Cohort's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTPPUGCAUPUGAU
Date   Source Headline
6th Aug 202111:51 amRNSDirector/PDMR Shareholding
6th Aug 20217:00 amRNSMCL wins contracts with MoD
5th Aug 20211:42 pmRNSDirector/PDMR Shareholding
5th Aug 20219:41 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSAppointment of Non-Executive Director
27th Jul 20217:00 amRNSPreliminary Results
14th Jul 202111:58 amRNSNotice of Results
7th Jul 20217:00 amRNSELAC SONAR wins EUR49m contract for Italian Navy
10th Jun 20213:35 pmRNSHolding(s) in Company
1st Jun 20214:41 pmRNSSecond Price Monitoring Extn
1st Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSTrading Update
25th May 20214:40 pmRNSSecond Price Monitoring Extn
25th May 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:01 pmRNSTotal Voting Rights
6th Apr 20212:10 pmRNSDirector/PDMR Shareholding
1st Apr 202110:28 amRNSTotal Voting Rights
1st Apr 202110:27 amRNSBlock listing Interim Review
31st Mar 20214:45 pmRNSHolding(s) in Company
29th Mar 20212:40 pmRNSSEA wins £25m contract with UK MoD
11th Mar 20217:00 amRNSContract Wins
3rd Mar 20212:05 pmRNSResponse to Press Speculation
26th Feb 20212:30 pmRNSTotal Voting Rights
24th Feb 20214:42 pmRNSBlock listing Interim Review
11th Feb 20215:41 pmRNSDirector/PDMR Shareholding
9th Feb 20219:30 amRNSEBT Purchase of Shares
8th Feb 20215:31 pmRNSDirector/PDMR Shareholding
29th Jan 202110:31 amRNSTotal Voting Rights
12th Jan 20216:10 pmRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSInterim Report
31st Dec 20209:22 amRNSTotal Voting Rights
14th Dec 20201:51 pmRNSEBT Purchase of Shares
11th Dec 20202:12 pmRNSDirector/PDMR Shareholding
10th Dec 20205:35 pmRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf Year Results
3rd Dec 20207:00 amRNSCompletion of Acquisition
30th Nov 202011:21 amRNSTotal Voting Rights
19th Nov 20207:00 amRNSNotice of Interim Results Date
4th Nov 20201:24 pmRNSTotal Voting Rights
30th Oct 20204:59 pmRNSTotal Voting Rights
26th Oct 20206:13 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSContract Wins
14th Oct 20202:53 pmRNSDirector/PDMR Shareholding
5th Oct 20205:58 pmRNSEBT purchase and exercise of Share Options
28th Sep 20202:36 pmRNSBlock Listing Application
25th Sep 20205:10 pmRNSDirector/PDMR Shareholding
21st Sep 20202:05 pmRNSEBT Purchase and Director Shareholdings
15th Sep 20203:39 pmRNSResult of AGM
15th Sep 20201:13 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSAGM Statement & First Quarter Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.